- Visibility 357 Views
- Downloads 290 Downloads
- Permissions
- DOI 10.18231/j.ijpns.2025.013
-
CrossMark
Pediatric Guillain-Barré Syndrome triggered by SARS-CoV-2: A case study and implications for post-viral neurological complications
- Author Details:
-
Hardik Shah *
-
Naiya Bhavsar
-
Lata Jha
-
Ashok Bhandari
-
Akshat Desai
Hardik Shah *
Naiya Bhavsar
Lata Jha
Ashok Bhandari
Akshat Desai
Guillain-Barré Syndrome (GBS) is a significant cause of acute, severe weakness in children, with Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) being the most common subtype. The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has been associated with various neurological manifestations, including GBS. We present the case of a 12-year-old male child who developed GBS after a past COVID-19 infection. Although the patient tested negative for SARS-CoV-2 via RT-PCR at the time of admission, he was positive for COVID-19 antibodies, suggesting a prior infection. The patient was treated with intravenous immunoglobulin (IVIG), with significant clinical improvement. This report highlights the potential association between COVID-19 and GBS in children and underscores the importance of recognizing post-infectious neurological complications.
Keywords: Extrapyramidal sign, Hallervorden-Spatz Disease, Dystonia, Dementia.
References
- Asbury AK. New concepts of Guillain-Barré syndrome. J Child Neurol. 2000;15(3):183–91.
- Levison LS, Thomsen RW, Markvardsen LK, Christensen DH, Sindrup SH, Andersen H. Pediatric Guillain-Barré Syndrome in a 30-Year Nationwide Cohort. Pediatr Neurol. 2020;107:57-63.
- Castagnoli R, Votto M, Licari A, Brambilla I, Bruno R, Perlini S, et al. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV- 2) Infection in Children and Adolescents: A Systematic Review. JAMA Pediatr. 2020;174(9):882–9.
- Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–90.
- Vonck K, Garrez I, De Herdt V, Hemelsoet D, Laureys G, Raedt R, et al. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2. Eur J Neurol. 2020;27(8):1578–7.
- Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(4):e741.
- Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S. et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41:1351–4.
- Camdessanche JP, Morel J, Pozzetto B, Tholance Y, Botelho-Nevers E. COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris). 2020;176(6):516–8.